Klotho hypermethylation in kidney biopsy tissue and peripheral blood mononuclear cells in chronic kidney disease patients by pyrosequencing

陈静,章晓燕,林静,张函,张晨,吴庆,方艺,丁小强

DOI: https://doi.org/10.3760/cma.j.issn.1001-7097.2013.07.001

2013-01-01

Abstract:Objective To assess the relationship between levels of Klotho hypermethylation of intrarenal and peripheral blood mononuclear cells(PBMC) and clinical and histological severity of the disease.Methods Intrarenal and PBMC levels of Klotho promoter methylation were quantified in 47 CKD patients by pyroseqencing.The results were compared with 47 nephrectomy specimens and PBMC of 48 healthy volunteers.Results Higher levels of Klotho promoter methylation were observed in both renal biopsy and PBMC at specific CpG sites in CKD patients compared to control[(17.04±6.42) ％ vs (9.34±2.43) ％,P＜0.01; (14.19±5.86) ％ vs (6.90±2.39)％,P＜0.01].The level of Klotho promoter methylation on PBMC was positively correlated with intrarenal level (r=0.811,P＜0.01).Using receiver operator characteristic curve analysis,PBMC level of Klotho promoter methylation had an area under the curve (AUC) of 0.958 (P ＜ 0.01) in predicting intralrenal Klotho promoter hypermethylation.Estimated glomerular filtration rate inversely correlated with intrarenal and PBMC levels of Klotho hypermethylation (r=-0.827,P＜ 0.01; r=-0.626,P＜0.01).Tubulointerstitial scarring positively correlated with intrarenal level of Klotho hypermethylation,as well as PBMC level of Klotho hypermethylation (r=0.865,P＜0.01; r=0.748,P＜0.01).There was no correlation between proteinuria and the level of Klotho promoter methylation of renal tissue or PBMC.Conclusions Klotho promoter methylation levels of intrarenal and PBMC are significantly elevated in CKD patients and correlated with clinical and histological severity.Klotho promoter hypermethylation may play an important role in renal fibrosis.The level of Klotho promoter methylation of PBMC may be a potential biomarker of intrarenal Klotho promoter hypermethylation.